Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

BACKGROUND: Fluticasone furoate (FF) is a novel, once-daily inhaled corticosteroid (ICS) that has been shown to improve lung function vs. placebo in asthma patients. This study evaluated the efficacy and safety of FF 50 mcg compared with placebo in asthma patients uncontrolled by non-ICS therapy. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Byrne, Paul M, Woodcock, Ashley, Bleecker, Eugene R, Bateman, Eric D, Lötvall, Jan, Forth, Richard, Medley, Hilary, Jacques, Loretta, Busse, William W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256920/
https://www.ncbi.nlm.nih.gov/pubmed/25108545
http://dx.doi.org/10.1186/s12931-014-0088-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256920/
https://www.ncbi.nlm.nih.gov/pubmed/25108545
http://dx.doi.org/10.1186/s12931-014-0088-z

Ejemplares similares